Announced Wed, 29 Apr · 17:38 IST
FY26 Results: Revenue declines 6%, PAT up 3.6% YoY
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹47.84
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+1.0+4.5-0.3+3.5+6.6+4.5-8.0+17.3+74.1—
Up moveDown movePending
AI summary
Colinz Laboratories reported FY26 revenue from operations of Rs 613.61 lakhs, down 6% from Rs 652.77 lakhs in FY25. PAT rose to Rs 51.45 lakhs vs Rs 49.66 lakhs (+3.6%). Q4 FY26 showed strong recovery with revenue at Rs 174.79 lakhs (+20% YoY) and PAT at Rs 17.12 lakhs. Operating cash flow swung to positive Rs 254.11 lakhs from negative Rs 145.37 lakhs. Cash position strengthened to Rs 852.91 lakhs. Auditor issued unqualified opinion.
Likely market impact
Mixed results: full-year revenue declined, but profitability and cash flows improved. Q4 momentum is a positive signal.